FAQ

Recurrent Digestive System Carcinoma

Known as: Recurrent Gastrointestinal System Cancer, Recurrent Gastrointestinal System Carcinoma 
The reemergence of carcinoma in any part of the digestive system after a period of remission.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-2016
02419772016

Related topics

Related topics

7 relations
Epithelial CellsEpitheliumGastrointestinal systemMalignant Epithelial Cell
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Recurrent Digestive System Carcinoma
cancer cell
Neoplastic Cell
Epithelial Cells
Gastrointestinal system
Epithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer
To determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined oxaliplatin, irinotecan, and S-1… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer
Background:The clinical significance of circulating tumour cell (CTC) detection in gastrointestinal (GI) cancer remains… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2010
2010
[Oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients].
The aim of this study was to introduce an oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer… (More)
Is this relevant?
2004
2004
A phase I study of immunotherapy with tumor cell-dendritic cell fusion vaccine in patients with advanced or recurrent gastrointestinal cancer.
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against… (More)
Is this relevant?
1999
1999
[Biochemical modulation of 5-FU--effect of low dose CDDP].
A pilot study of continuous or intermittent low dose 5-FU and cisplatin chemotherapy (low-dose FP therapy) was conducted at the… (More)
Is this relevant?
1996
1996
Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C.
This chapter reported the pharmacokinetics and the toxicities of mitomycin-c (MMC) when administered as a hyperthermic… (More)
Is this relevant?
1990
1990
[Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90…
Early phase II study in patients with advanced and recurrent gastrointestinal cancer was conducted from August 1986 through… (More)
Is this relevant?
1989
1989
Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture.
Tumour spread onto peritoneal surfaces is frequent in patients who have recurrent gastrointestinal cancer. In this study the… (More)
Is this relevant?
1985
1985
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer.
In our study of patients with resected primary gastrointestinal cancer, slope analysis of the post-operatively increasing… (More)
Is this relevant?
1977
1977
The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.
Since 1972 plasma CEA levels of 25 cancer patients have been assayed to evaluate the reliability of CEA as an early indicator of… (More)
Is this relevant?